Advisory Services Network, LLC Myovant Sciences Ltd. Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$24.03 - $27.02 $7,209 - $8,106	300 New	300 $8,000
Q3 2021 Nov 05, 2021	SELL	$18.94 - $26.99 $50,191 - $71,523	-2,650 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$17.07 - $24.56 $45,235 - $65,084	2,650 New	2,650 $60,000
Q1 2021 May 24, 2021	SELL	$20.46 - $25.18 $64,449 - $79,317	-3,150 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$14.05 - $22.6 $44,257 - $71,190	3,150 New	3,150 $44,000
Q2 2020 Aug 10, 2020	SELL	$7.34 - $20.84 $51,380 - $145,880	-7,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.55 - $14.76 $38,645 - $87,084	5,900 Added 536.36%	7,000 $53,000
Q4 2019 Feb 04, 2020	BUY	$4.2 - $19.21 $4,620 - $21,131	1,100 New	1,100 $17,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.